ClearPoint Neuro, Inc.
CLPT
$9.42
-$0.09-0.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.79M | -5.89M | -5.84M | -6.03M | -5.39M |
| Total Depreciation and Amortization | 752.00K | 426.00K | 626.00K | 334.00K | 471.00K |
| Total Amortization of Deferred Charges | 122.00K | 39.00K | 21.00K | -- | 0.00 |
| Total Other Non-Cash Items | 2.20M | 2.34M | 2.44M | 2.13M | 1.91M |
| Change in Net Operating Assets | -7.37M | -35.00K | 197.00K | -2.61M | 1.76M |
| Cash from Operations | -12.08M | -3.12M | -2.55M | -6.17M | -1.24M |
| Capital Expenditure | -49.00K | -199.00K | -91.00K | -183.00K | -263.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 1.14M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.09M | -199.00K | -91.00K | -183.00K | -263.00K |
| Total Debt Issued | 19.43M | 0.00 | 28.65M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 326.00K | 0.00 | 3.60M | 21.00K | 121.00K |
| Repurchase of Common Stock | -195.00K | 0.00 | -356.00K | -1.31M | -84.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 78.00K | -78.00K | -- |
| Cash from Financing | 19.56M | 0.00 | 31.98M | -1.36M | 37.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.57M | -3.32M | 29.33M | -7.72M | -1.47M |